The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insulin Delivery Devices Market Research Report 2025

Global Insulin Delivery Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1922769

No of Pages : 109

Ask Your Query

Synopsis

Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

The global Insulin Delivery Devices market was valued at US$ 10580 million in 2023 and is anticipated to reach US$ 14100 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.

In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.

This report aims to provide a comprehensive presentation of the global market for Insulin Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Delivery Devices.

Report Scope

The Insulin Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic
  • Animas
  • Beta Bionics
  • Cellnovo
  • Copernicus
  • Dance Biopharm
  • Debiotech
  • Insulet
  • MannKind
  • Owen Mumford
  • Roche
  • SOOIL
  • Tandem Diabetes Care
  • Valeritas
  • West Pharma
  • Ypsomed

Segment by Type

  • Insulin Pens
  • Insulin Pumps
  • Insulin Syringes
  • Others

Segment by Application

  • Patients/Homecare
  • Hospitals & Clinics

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Insulin Delivery Devices Market Overview
1.1 Product Overview and Scope of Insulin Delivery Devices
1.2 Insulin Delivery Devices Segment by Type
1.2.1 Global Insulin Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Insulin Delivery Devices Segment by Application
1.3.1 Global Insulin Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Patients/Homecare
1.3.3 Hospitals & Clinics
1.4 Global Insulin Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Delivery Devices Revenue 2019-2030
1.4.2 Global Insulin Delivery Devices Sales 2019-2030
1.4.3 Global Insulin Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Delivery Devices Market Competition by Manufacturers
2.1 Global Insulin Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Delivery Devices, Product Type & Application
2.7 Insulin Delivery Devices Market Competitive Situation and Trends
2.7.1 Insulin Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Delivery Devices Players Market Share by Revenue
2.7.3 Global Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Delivery Devices Retrospective Market Scenario by Region
3.1 Global Insulin Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Delivery Devices Global Insulin Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Insulin Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Insulin Delivery Devices Sales by Region: 2025-2030
3.3 Global Insulin Delivery Devices Global Insulin Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Insulin Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Insulin Delivery Devices Revenue by Region: 2025-2030
3.4 North America Insulin Delivery Devices Market Facts & Figures by Country
3.4.1 North America Insulin Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Insulin Delivery Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Insulin Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Insulin Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Insulin Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Insulin Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Insulin Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Insulin Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Insulin Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Insulin Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Insulin Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Insulin Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Insulin Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Insulin Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Insulin Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Insulin Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Insulin Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Insulin Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Insulin Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Insulin Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin Delivery Devices Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Insulin Delivery Devices Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Insulin Delivery Devices Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Insulin Delivery Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Insulin Delivery Devices Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Animas
6.6.1 Animas Corporation Information
6.6.2 Animas Description and Business Overview
6.6.3 Animas Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Animas Insulin Delivery Devices Product Portfolio
6.6.5 Animas Recent Developments/Updates
6.7 Beta Bionics
6.6.1 Beta Bionics Corporation Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beta Bionics Insulin Delivery Devices Product Portfolio
6.7.5 Beta Bionics Recent Developments/Updates
6.8 Cellnovo
6.8.1 Cellnovo Corporation Information
6.8.2 Cellnovo Description and Business Overview
6.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cellnovo Insulin Delivery Devices Product Portfolio
6.8.5 Cellnovo Recent Developments/Updates
6.9 Copernicus
6.9.1 Copernicus Corporation Information
6.9.2 Copernicus Description and Business Overview
6.9.3 Copernicus Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Copernicus Insulin Delivery Devices Product Portfolio
6.9.5 Copernicus Recent Developments/Updates
6.10 Dance Biopharm
6.10.1 Dance Biopharm Corporation Information
6.10.2 Dance Biopharm Description and Business Overview
6.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dance Biopharm Insulin Delivery Devices Product Portfolio
6.10.5 Dance Biopharm Recent Developments/Updates
6.11 Debiotech
6.11.1 Debiotech Corporation Information
6.11.2 Debiotech Insulin Delivery Devices Description and Business Overview
6.11.3 Debiotech Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Debiotech Insulin Delivery Devices Product Portfolio
6.11.5 Debiotech Recent Developments/Updates
6.12 Insulet
6.12.1 Insulet Corporation Information
6.12.2 Insulet Insulin Delivery Devices Description and Business Overview
6.12.3 Insulet Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Insulet Insulin Delivery Devices Product Portfolio
6.12.5 Insulet Recent Developments/Updates
6.13 MannKind
6.13.1 MannKind Corporation Information
6.13.2 MannKind Insulin Delivery Devices Description and Business Overview
6.13.3 MannKind Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MannKind Insulin Delivery Devices Product Portfolio
6.13.5 MannKind Recent Developments/Updates
6.14 Owen Mumford
6.14.1 Owen Mumford Corporation Information
6.14.2 Owen Mumford Insulin Delivery Devices Description and Business Overview
6.14.3 Owen Mumford Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Owen Mumford Insulin Delivery Devices Product Portfolio
6.14.5 Owen Mumford Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Insulin Delivery Devices Description and Business Overview
6.15.3 Roche Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Roche Insulin Delivery Devices Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 SOOIL
6.16.1 SOOIL Corporation Information
6.16.2 SOOIL Insulin Delivery Devices Description and Business Overview
6.16.3 SOOIL Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 SOOIL Insulin Delivery Devices Product Portfolio
6.16.5 SOOIL Recent Developments/Updates
6.17 Tandem Diabetes Care
6.17.1 Tandem Diabetes Care Corporation Information
6.17.2 Tandem Diabetes Care Insulin Delivery Devices Description and Business Overview
6.17.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tandem Diabetes Care Insulin Delivery Devices Product Portfolio
6.17.5 Tandem Diabetes Care Recent Developments/Updates
6.18 Valeritas
6.18.1 Valeritas Corporation Information
6.18.2 Valeritas Insulin Delivery Devices Description and Business Overview
6.18.3 Valeritas Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Valeritas Insulin Delivery Devices Product Portfolio
6.18.5 Valeritas Recent Developments/Updates
6.19 West Pharma
6.19.1 West Pharma Corporation Information
6.19.2 West Pharma Insulin Delivery Devices Description and Business Overview
6.19.3 West Pharma Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.19.4 West Pharma Insulin Delivery Devices Product Portfolio
6.19.5 West Pharma Recent Developments/Updates
6.20 Ypsomed
6.20.1 Ypsomed Corporation Information
6.20.2 Ypsomed Insulin Delivery Devices Description and Business Overview
6.20.3 Ypsomed Insulin Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Ypsomed Insulin Delivery Devices Product Portfolio
6.20.5 Ypsomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Delivery Devices Industry Chain Analysis
7.2 Insulin Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Delivery Devices Production Mode & Process
7.4 Insulin Delivery Devices Sales and Marketing
7.4.1 Insulin Delivery Devices Sales Channels
7.4.2 Insulin Delivery Devices Distributors
7.5 Insulin Delivery Devices Customers
8 Insulin Delivery Devices Market Dynamics
8.1 Insulin Delivery Devices Industry Trends
8.2 Insulin Delivery Devices Market Drivers
8.3 Insulin Delivery Devices Market Challenges
8.4 Insulin Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Insulin Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Delivery Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Delivery Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Delivery Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Delivery Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Insulin Delivery Devices Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Insulin Delivery Devices Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Delivery Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Delivery Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Insulin Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Insulin Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Insulin Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Insulin Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Insulin Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Insulin Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Insulin Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Insulin Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insulin Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insulin Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Insulin Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Insulin Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Delivery Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Insulin Delivery Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Insulin Delivery Devices Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Delivery Devices Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Delivery Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Delivery Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Delivery Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Delivery Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Insulin Delivery Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Insulin Delivery Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Insulin Delivery Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Insulin Delivery Devices Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Delivery Devices Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Delivery Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Delivery Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Delivery Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Delivery Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Delivery Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Insulin Delivery Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Insulin Delivery Devices Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Insulin Delivery Devices Product
Table 79. Sanofi Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. BD Insulin Delivery Devices Product
Table 84. BD Recent Developments/Updates
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eli Lilly Insulin Delivery Devices Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Medtronic Corporation Information
Table 91. Medtronic Description and Business Overview
Table 92. Medtronic Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Medtronic Insulin Delivery Devices Product
Table 94. Medtronic Recent Developments/Updates
Table 95. Animas Corporation Information
Table 96. Animas Description and Business Overview
Table 97. Animas Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Animas Insulin Delivery Devices Product
Table 99. Animas Recent Developments/Updates
Table 100. Beta Bionics Corporation Information
Table 101. Beta Bionics Description and Business Overview
Table 102. Beta Bionics Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Beta Bionics Insulin Delivery Devices Product
Table 104. Beta Bionics Recent Developments/Updates
Table 105. Cellnovo Corporation Information
Table 106. Cellnovo Description and Business Overview
Table 107. Cellnovo Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Cellnovo Insulin Delivery Devices Product
Table 109. Cellnovo Recent Developments/Updates
Table 110. Copernicus Corporation Information
Table 111. Copernicus Description and Business Overview
Table 112. Copernicus Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Copernicus Insulin Delivery Devices Product
Table 114. Copernicus Recent Developments/Updates
Table 115. Dance Biopharm Corporation Information
Table 116. Dance Biopharm Description and Business Overview
Table 117. Dance Biopharm Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Dance Biopharm Insulin Delivery Devices Product
Table 119. Dance Biopharm Recent Developments/Updates
Table 120. Debiotech Corporation Information
Table 121. Debiotech Description and Business Overview
Table 122. Debiotech Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Debiotech Insulin Delivery Devices Product
Table 124. Debiotech Recent Developments/Updates
Table 125. Insulet Corporation Information
Table 126. Insulet Description and Business Overview
Table 127. Insulet Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Insulet Insulin Delivery Devices Product
Table 129. Insulet Recent Developments/Updates
Table 130. MannKind Corporation Information
Table 131. MannKind Description and Business Overview
Table 132. MannKind Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. MannKind Insulin Delivery Devices Product
Table 134. MannKind Recent Developments/Updates
Table 135. Owen Mumford Corporation Information
Table 136. Owen Mumford Description and Business Overview
Table 137. Owen Mumford Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Owen Mumford Insulin Delivery Devices Product
Table 139. Owen Mumford Recent Developments/Updates
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Roche Insulin Delivery Devices Product
Table 144. Roche Recent Developments/Updates
Table 145. SOOIL Corporation Information
Table 146. SOOIL Description and Business Overview
Table 147. SOOIL Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. SOOIL Insulin Delivery Devices Product
Table 149. SOOIL Recent Developments/Updates
Table 150. Tandem Diabetes Care Corporation Information
Table 151. Tandem Diabetes Care Description and Business Overview
Table 152. Tandem Diabetes Care Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Tandem Diabetes Care Insulin Delivery Devices Product
Table 154. Tandem Diabetes Care Recent Developments/Updates
Table 155. Valeritas Corporation Information
Table 156. Valeritas Description and Business Overview
Table 157. Valeritas Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Valeritas Insulin Delivery Devices Product
Table 159. Valeritas Recent Developments/Updates
Table 160. West Pharma Corporation Information
Table 161. West Pharma Description and Business Overview
Table 162. West Pharma Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. West Pharma Insulin Delivery Devices Product
Table 164. West Pharma Recent Developments/Updates
Table 165. Ypsomed Corporation Information
Table 166. Ypsomed Description and Business Overview
Table 167. Ypsomed Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. Ypsomed Insulin Delivery Devices Product
Table 169. Ypsomed Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Insulin Delivery Devices Distributors List
Table 173. Insulin Delivery Devices Customers List
Table 174. Insulin Delivery Devices Market Trends
Table 175. Insulin Delivery Devices Market Drivers
Table 176. Insulin Delivery Devices Market Challenges
Table 177. Insulin Delivery Devices Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Delivery Devices
Figure 2. Global Insulin Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Delivery Devices Market Share by Type in 2023 & 2030
Figure 4. Insulin Pens Product Picture
Figure 5. Insulin Pumps Product Picture
Figure 6. Insulin Syringes Product Picture
Figure 7. Others Product Picture
Figure 8. Global Insulin Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Insulin Delivery Devices Market Share by Application in 2023 & 2030
Figure 10. Patients/Homecare
Figure 11. Hospitals & Clinics
Figure 12. Global Insulin Delivery Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insulin Delivery Devices Market Size (2019-2030) & (US$ Million)
Figure 14. Global Insulin Delivery Devices Sales (2019-2030) & (K Units)
Figure 15. Global Insulin Delivery Devices Average Price (USD/Unit) & (2019-2030)
Figure 16. Insulin Delivery Devices Report Years Considered
Figure 17. Insulin Delivery Devices Sales Share by Manufacturers in 2023
Figure 18. Global Insulin Delivery Devices Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Insulin Delivery Devices Players: Market Share by Revenue in 2023
Figure 20. Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Insulin Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Insulin Delivery Devices Sales Market Share by Country (2019-2030)
Figure 23. North America Insulin Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Insulin Delivery Devices Sales Market Share by Country (2019-2030)
Figure 27. Europe Insulin Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 28. Germany Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Insulin Delivery Devices Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Insulin Delivery Devices Revenue Market Share by Region (2019-2030)
Figure 35. China Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Insulin Delivery Devices Sales Market Share by Country (2019-2030)
Figure 46. Latin America Insulin Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Insulin Delivery Devices Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Insulin Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Insulin Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Insulin Delivery Devices by Type (2019-2030)
Figure 56. Global Revenue Market Share of Insulin Delivery Devices by Type (2019-2030)
Figure 57. Global Insulin Delivery Devices Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Insulin Delivery Devices by Application (2019-2030)
Figure 59. Global Revenue Market Share of Insulin Delivery Devices by Application (2019-2030)
Figure 60. Global Insulin Delivery Devices Price (USD/Unit) by Application (2019-2030)
Figure 61. Insulin Delivery Devices Value Chain
Figure 62. Insulin Delivery Devices Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock